Barry Crittenden

Barry Crittenden

Company: Terns Pharmaceuticals

Job title: Executive Director, Clinical Research


Discovering the Future State of Combination Treatment for NASH 3:00 pm

• Deep diving into the limitations of single agent treatments • Understanding the rationale for combination treatment • Investigating current and future combination approachesRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.